Apellis Pharmaceuticals, Inc. (APLS)
25.24
+0.07
(+0.28%)
USD |
NASDAQ |
Dec 30, 16:00
25.24
0.00 (0.00%)
After-Hours: 20:00
Apellis Pharmaceuticals Market Cap: 3.193B for Dec. 30, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Biogen, Inc. | 25.88B |
| Amicus Therapeutics, Inc. | 4.397B |
| Fortress Biotech, Inc. | 111.12M |
| Ultragenyx Pharmaceutical, Inc. | 2.198B |
| Fulcrum Therapeutics, Inc. | 613.70M |
Market Cap Related Metrics
| PE Ratio | 84.98 |
| PS Ratio | 3.142 |
| Price to Book Value | 7.960 |
| Price to Free Cash Flow | 40.61 |
| Price | 25.24 |
| Earnings Yield | 1.18% |
| Operating PE Ratio | 39.71 |
| Normalized PE Ratio | 84.98 |